Combination of GHRH antagonists and docetaxel shows experimental effectiveness for the treatment of triple-negative breast cancers

S. Seitz, F. G. Rick, A. V. Schally, A. Treszl, F. Hohla, L. Szalontay, M. Zarandi, O. Ortmann, J. B. Engel, S. Buchholz

Research output: Contribution to journalArticlepeer-review

21 Scopus citations

Fingerprint

Dive into the research topics of 'Combination of GHRH antagonists and docetaxel shows experimental effectiveness for the treatment of triple-negative breast cancers'. Together they form a unique fingerprint.

Medicine & Life Sciences